Home
About Us
Subject
Browse
0
Sign In
once per day
Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Load More
More Info